Vaccine maker Bavarian Nordic on Monday said it has agreed in principle to a roughly $3 billion take-private offer from private equity firms Nordic Capital and Permira.

COPENHAGEN, Denmark, July 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its ...

COPENHAGEN, Denmark, July 31, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash consi ...

The offer price is DKK 233 in cash for each share in Bavarian Nordic (the “Offer Price”), valuing the transaction equity of Bavarian Nordic at approx. DKK 19 billion based on the fully diluted ...

COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose ...

A consortium led by Nordic Capital and Permira has made an around $3 billion offer to buy all shares in Bavarian Nordic, the vaccine maker said on Monday. Innosera, a newly formed company controlled ...

About Bavarian Nordic Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines.

COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose, virus-like ...

The directors of the vaccine maker said the offer from Permira and Nordic Capital was an attractive proposal and recommended that shareholders accept it.

Bavarian Nordic A/S was the biggest leader among large stocks during the session, soaring 21.0%, and Neste Oyj jumped 12.8%. Medicover AB Series B rounded out the top three leaders on Thursday ...

Investing.com -- Bavarian Nordic (CSE: BAVA) has agreed to a 19 billion Danish kroner ($2.99 billion) takeover offer from private-equity firms Permira and Nordic Capital. The Danish vaccine maker ...

COPENHAGEN, Denmark, July 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the sale of its Priority Review Voucher (PRV). Upon completion, the company received a cash ...